Druggability Analysis and Structural Classification of Bromodomain Acetyl-lysine Binding Sites

Citations Over TimeTop 10% of 2012 papers

Abstract

Bromodomains are readers of the epigenetic code that specifically bind acetyl-lysine containing recognition sites on proteins. Recently the BET family of bromodomains has been demonstrated to be druggable through the discovery of potent inhibitors, sparking an interest in protein-protein interaction inhibitors that directly target gene transcription. Here, we assess the druggability of diverse members of the bromodomain family using SiteMap and show that there are significant differences in predicted druggability. Furthermore, we trace these differences in druggability back to unique amino acid signatures in the bromodomain acetyl-lysine binding sites. These signatures were then used to generate a new classification of the bromodomain family, visualized as a classification tree. This represents the first analysis of this type for the bromodomain family and can prove useful in the discovery of inhibitors, particularly for anticipating screening hit rates, identifying inhibitors that can be explored for lead hopping approaches, and selecting proteins for selectivity screening.

Related Papers

• → Druggability Analysis and Structural Classification of Bromodomain Acetyl-lysine Binding Sites(2012)272 cited
• → Targeting Low-Druggability Bromodomains: Fragment Based Screening and Inhibitor Design against the BAZ2B Bromodomain(2013)103 cited
• → DREADDs: novel tools for drug discovery and development(2013)93 cited
• → Small Molecule Bromodomain Inhibitors(2012)45 cited
• → Structural genomics and drug discovery: all in the family(2008)43 cited